Stay updated on CPX-351 and Ivosidenib in IDH1 AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.

Latest updates to the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page
- Check2 days agoChange DetectedA new version entry was added on 2025-11-20 showing updated study status and recruitment details. The history now reflects the latest changes to the trial record.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedRevision history now includes the addition of v3.5.0 and the deletion of v3.4.3.SummaryDifference0.1%

- Check24 days agoChange DetectedRevision: v3.4.3 was added to the history and Revision: v3.4.2 was removed. This update reflects administrative changes to the record history.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.4.2 to the history, and removed the site-wide funding/operating-status notice along with the prior Revision: v3.4.1 entry. These changes relate to site-wide notices and version labeling rather than the core study content.SummaryDifference0.7%

- Check60 days agoChange DetectedAdded a government funding lapse notice and an operation status banner. Updated the site revision to v3.4.1, replacing v3.4.0.SummaryDifference0.7%

- Check67 days agoChange DetectedUI enhancements on the Record History page include a new 'Show glossary' option, color-coded highlights for changes (green for additions, red for deletions), and updated labels/notes such as 'No FEAR Act Data' and revision metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to CPX-351 and Ivosidenib in IDH1 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.